Financials
- Market Capitalization 2.72 B
- Employee 10
- Founded 2014
- CEO N/A
- Website www.regencellbioscience.com
- Headquarter Cayman Islands
- FIGI UNKNOWN
- Industry Fabricants de Médicaments — Spécialités et Génériques
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-23.67
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1274 | AMRX Amneal Pharmaceuticals, Inc. - Class A Common Stock | 17.54 USD | -2.61% | -1.79% | -3.73% | +66.26% | 5.60 B USD | ||
| 1492 | INDV Indivior Pharmaceuticals, Inc. - Common Stock | 34.87 USD | -1.22% | -4.54% | -13.22% | +3.78% | 4.12 B USD | ||
| 1841 | SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 43.73 USD | -1.04% | -4.62% | -5.55% | -19.02% | 2.54 B USD | ||
| 1859 | PBH Prestige Consumer Healthcare Inc. Common Stock | 52.41 USD | +2.38% | +2.50% | +2.91% | -23.56% | 2.48 B USD |